The European Commission has approved the use of AstraZeneca’s drug, Fasenra, to treat a condition called EGPA.
A recent trial showed that nearly 60% of patients using Fasenra reached remission. The European Commission has approved Fasenra, a […]
A recent trial showed that nearly 60% of patients using Fasenra reached remission. The European Commission has approved Fasenra, a […]
At a conference on clinical trials in New England, the U.S. Customs and Border Protection (CBP) warned researchers about common
The MVA-BN vaccine, known as Jynneos in the US and Imvanex in Europe, is being tested to see if it
The US regulator is currently assessing an additional application for VTAMA cream to treat atopic dermatitis. Organon recently acquired Dermavant